Amanpour and Company ✓

@AmanpourCoPBS · Global · joined 27 Jul 2018

#AmanpourPBS examines global and domestic news with @amanpour and contributors. Weeknights on @PBS-check local listings. 212-560-2888. programming@thirteen.org

28 232Followers

2 338Following

7 115Posts total

61.8KViews on collected posts

Postingan terbaru

Amanpour and Company ✓@AmanpourCoPBS9 Jul

@AmanpourCoPBS @EricTopol @WalterIsaacson Your show has become the Middle East Pain Hour. There are other things going on in the world 10 views · 0 likes · 0 reposts · 0 replies Open on X →

Amanpour and Company ✓@AmanpourCoPBS12 Jul 2025

@AmanpourCoPBS @EricTopol @WalterIsaacson GLP-1s don’t just reduce appetite—they mimic a prolonged fast. And yes, that can clear junk proteins… but it also shifts water structure, redox balance, and even astrocyte hydration states. I’m seeing the short-term benefits. But the lon 64 views · 1 likes · 0 reposts · 1 replies Open on X →

Amanpour and Company ✓@AmanpourCoPBS12 Jul 2025

@AmanpourCoPBS @EricTopol @WalterIsaacson p-tau217 isn’t a static number—it’s a dynamic spike. @EricTopol’s GLP-1 vision is promising, but it’s still 2D thinking. With SpikeWatch + Spike-to-pTau217, we track, predict, and flatten the curve—in real time. This is 3D medicine, not s 108 views · 1 likes · 0 reposts · 0 replies Open on X →

Amanpour and Company ✓@AmanpourCoPBS11 Jul 2025

Dr. Eric Topol shares his science-backed approach to achieving longevity and becoming a "Super Ager." @EricTopol @WalterIsaacson https://t.co/lskZat7zQF 33.7K views · 56 likes · 10 reposts · 26 replies Open on X →

Amanpour and Company ✓@AmanpourCoPBS11 Jul 2025

Could GLP-1 drugs be used to fight Alzheimer's disease? Dr. Eric Topol, author of “Super Agers,” explains the possibilities. @EricTopol @WalterIsaacson https://t.co/9qGfNKGCTg

2:12

22K views · 141 likes · 39 reposts · 25 replies Open on X →

Amanpour and Company ✓@AmanpourCoPBS10 Jul 2025

Jeff Bieber, co-director of the new PBS documentary “Hannah Arendt: Facing Tyranny,” explains the origins behind the phrase she coined, “the banality of evil.” @MichelMcQMartin https://t.co/7Wl2mikLrM

2:14

1.9K views · 20 likes · 13 reposts · 14 replies Open on X →

Amanpour and Company ✓@AmanpourCoPBS9 Jul 2025

Will Governor Andy Beshear (D-KY) run for President? @GovAndyBeshear @MichelMcQMartin https://t.co/FO2fu6wAbu

1:18

1.4K views · 15 likes · 7 reposts · 12 replies Open on X →

Amanpour and Company ✓@AmanpourCoPBS

2.7K views · 0 likes · 0 reposts · 0 replies Open on X →

Dibandingkan akun berukuran sama

1 postingan dari 90 hari terakhir, dibandingkan dengan rentang 10K–100K pengikut. menjangkau lebih sedikit orang dibanding akun seukurannya.

Median tayangan10akun ini1 041median untuk 10K–100K

Jangkauan, %0.04%akun ini3.78%median untuk 10K–100K

Interaksi, %0.00%akun ini1.69%median untuk 10K–100K

Metrik	Akun ini	Median untuk 10K–100K	Rasio
Median tayangan per postingan	10	1 041	0.01×
Jangkauan (tayangan ÷ pengikut)	0.04%	3.78%	0.01×
Tingkat interaksi	0.00%	1.69%	0.00×

Akun lain pada rentang ini → Bandingkan dengan akun lain → Bagaimana tolok ukur ini disusun →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

2.7K

1.4K9 Jul

1.9K10 Jul

22K11 Jul

33.7K

10812 Jul

109 Jul

Last 8 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.00%

2.73%9 Jul

2.44%10 Jul

0.97%11 Jul

0.28%

0.93%12 Jul

3.12%

0.00%9 Jul

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.69%.

What the audience does

Likes48.3%234 in total

Reposts14.3%69 in total

Replies16.1%78 in total

Quotes2.9%14 in total

Bookmarks18.4%89 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.